352
Cancer drugs to be!
An international team of scientists has completed the next stage of work on a cure for cancer - the virus deliberately damaging cancer cells and does not affect healthy tissue. Tests on a group of 23 volunteers with different types of cancer have confirmed that the virus infects only the cancer cells.
Development of other researchers on the use of viruses in cancer involve the introduction of the virus directly into the tumor. In this case, a different approach - a virus is injected into the blood, and then he finds a tumor. "Intravenous injection of the virus is needed, as it allows us to work on tumors throughout the body, not just the ones in which you can inject the virus directly," - said Professor John Bell from the University of Ottawa.
JX-594 virus was developed a few years on the basis of the virus from the smallpox vaccine. Results to date results allow oncologists to argue that the chosen approach when creating a promising and promising.
As for the impact on the cancer cells, the results are positive, although tests are still far from complete. The first test was carried out on human volunteers to evaluate the safety of the virus, and because the people was administered only one dose.
Observations for several weeks showed that the virus replicates in tumor free seven of eight patients receiving high doses. In six patients stopped the spread of the tumor. The result was even when exposed to such a difficult to treat type of cancer as mesothelioma.
According to Bell, "the virus is able to consistently and selectively replicate itself in cancer tissues." He believes that "one day viruses and other biological therapies could seriously change the approach to cancer treatment».
Source: cnews.ru
Source:
Development of other researchers on the use of viruses in cancer involve the introduction of the virus directly into the tumor. In this case, a different approach - a virus is injected into the blood, and then he finds a tumor. "Intravenous injection of the virus is needed, as it allows us to work on tumors throughout the body, not just the ones in which you can inject the virus directly," - said Professor John Bell from the University of Ottawa.
JX-594 virus was developed a few years on the basis of the virus from the smallpox vaccine. Results to date results allow oncologists to argue that the chosen approach when creating a promising and promising.
As for the impact on the cancer cells, the results are positive, although tests are still far from complete. The first test was carried out on human volunteers to evaluate the safety of the virus, and because the people was administered only one dose.
Observations for several weeks showed that the virus replicates in tumor free seven of eight patients receiving high doses. In six patients stopped the spread of the tumor. The result was even when exposed to such a difficult to treat type of cancer as mesothelioma.
According to Bell, "the virus is able to consistently and selectively replicate itself in cancer tissues." He believes that "one day viruses and other biological therapies could seriously change the approach to cancer treatment».
Source: cnews.ru
Source:
